Published in Invest Ophthalmol Vis Sci on November 01, 2007
Predictors of adherence to glaucoma treatment in a multisite study. Ann Behav Med (2015) 1.48
Patient satisfaction with fixed-combination bimatoprost/timolol ophthalmic solution: a survey study in patients with glaucoma in China. Patient Prefer Adherence (2017) 1.39
Objective assessment of compliance and persistence among patients treated for glaucoma and ocular hypertension: a systematic review. Patient Prefer Adherence (2011) 1.17
Influence of parental health literacy and dosing responsibility on pediatric glaucoma medication adherence. Arch Ophthalmol (2012) 1.10
Compliance and adherence in glaucoma management. Indian J Ophthalmol (2011) 1.00
Measurement of treatment compliance using a medical device for glaucoma patients associated with intraocular pressure control: a survey. Clin Ophthalmol (2010) 1.00
Scoring and psychometric properties of the Eye-Drop Satisfaction Questionnaire (EDSQ), an instrument to assess satisfaction and compliance with glaucoma treatment. BMC Ophthalmol (2010) 0.98
The influence of health literacy level on an educational intervention to improve glaucoma medication adherence. Patient Educ Couns (2011) 0.93
Glaucoma medication adherence: room for improvement in both performance and measurement. Arch Ophthalmol (2011) 0.90
Impact of patient access to Internet health records on glaucoma medication: randomized controlled trial. J Med Internet Res (2014) 0.87
Glaucoma severity and medication adherence in a county hospital population. Ophthalmology (2013) 0.87
Use of health care claims data to study patients with ophthalmologic conditions. Ophthalmology (2014) 0.86
Persistence on prostaglandin ocular hypotensive therapy: an assessment using medication possession and days covered on therapy. BMC Ophthalmol (2010) 0.85
Identification of persons with incident ocular diseases using health care claims databases. Am J Ophthalmol (2013) 0.85
First-year treatment costs among new initiators of topical prostaglandin analogs. Clin Ophthalmol (2009) 0.85
Cost-effectiveness of medications compared with laser trabeculoplasty in patients with newly diagnosed open-angle glaucoma. Arch Ophthalmol (2012) 0.85
Two-year treatment patterns and costs in glaucoma patients initiating treatment with prostaglandin analogs. Clin Ophthalmol (2010) 0.84
Efficacy and safety of switching to travoprost/timolol fixed-combination therapy from latanoprost monotherapy. Jpn J Ophthalmol (2012) 0.83
The association between compliance with recommended follow-up and glaucomatous disease severity in a county hospital population. Am J Ophthalmol (2013) 0.83
Are you compliant with addressing glaucoma adherence? Am J Ophthalmol (2010) 0.83
Adjunctive therapy patterns in glaucoma patients using prostaglandin analogs. Clin Ophthalmol (2014) 0.82
Factors associated with adherence to glaucoma pharmacotherapy in the primary care setting. Fam Pract (2014) 0.82
Protocol for a randomised controlled trial to estimate the effects and costs of a patient centred educational intervention in glaucoma management. BMC Ophthalmol (2012) 0.81
Medication documentation in a primary care network serving North Carolina medicaid patients: results of a cross-sectional chart review. BMC Fam Pract (2012) 0.81
Progress toward personalized medicine for glaucoma. Expert Rev Ophthalmol (2009) 0.80
Analysis of Factors Affecting Patients' Compliance to Topical Antiglaucoma Medications in Egypt as a Developing Country Model. J Ophthalmol (2015) 0.79
Development and validation of a predictive model for nonadherence with once-daily glaucoma medications. Ophthalmology (2013) 0.79
Adherence to Glaucoma Medications Over 12 Months in Two US Community Pharmacy Chains. J Clin Med (2016) 0.79
Electronic compliance monitoring of topical treatment after ophthalmic surgery. Int Ophthalmol (2010) 0.78
Glaucoma patients' trust in the physician. J Ophthalmol (2009) 0.78
First-year treatment costs among new initiators of topical prostaglandin analogs: pooled results. Clin Ophthalmol (2010) 0.78
Impact of the introduction of generic latanoprost on glaucoma medication adherence. Ophthalmology (2015) 0.78
Persistence with topical glaucoma therapy among newly diagnosed Japanese patients. Jpn J Ophthalmol (2013) 0.77
Patient adherence and persistence with topical ocular hypotensive therapy in real-world practice: a comparison of bimatoprost 0.01% and travoprost Z 0.004% ophthalmic solutions. Clin Ophthalmol (2014) 0.76
Newly Diagnosed Primary Open-Angle Glaucoma Randomized to 2 Trabecular Bypass Stents or Prostaglandin: Outcomes Through 36 Months. Ophthalmol Ther (2016) 0.76
Psychometrics of a new questionnaire to assess glaucoma adherence: the Glaucoma Treatment Compliance Assessment Tool (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc (2013) 0.76
Characteristics of respondents with glaucoma and dry eye in a national panel survey. Clin Ophthalmol (2009) 0.76
Identification of noncompliant glaucoma patients using Bayesian networks and the Eye-Drop Satisfaction Questionnaire. Clin Ophthalmol (2010) 0.76
Accuracy of Patient-reported Adherence to Glaucoma Medications on a Visual Analog Scale Compared With Electronic Monitors. Clin Ther (2015) 0.76
Primary care physicians' role perception and self-reported performance in glaucoma care: a survey study. BMC Res Notes (2015) 0.75
The Effect of Counseling on Cataract Patient Knowledge, Decisional Conflict, and Satisfaction. Ophthalmic Epidemiol (2015) 0.75
Feasibility study of sustained-release travoprost punctum plug for intraocular pressure reduction in an Asian population. Clin Ophthalmol (2016) 0.75
Medical Management of Glaucoma in the 21st Century from a Canadian Perspective. J Ophthalmol (2016) 0.75
Micro-invasive glaucoma surgery (MIGS): a review of surgical procedures using stents. Clin Ophthalmol (2017) 0.75
Gene transfer to the outflow tract. Exp Eye Res (2016) 0.75
Challenges in the management of glaucoma in developing countries. Taiwan J Ophthalmol (2016) 0.75
The definition and classification of glaucoma in prevalence surveys. Br J Ophthalmol (2002) 8.35
Cost of lost productive work time among US workers with depression. JAMA (2003) 5.13
Determinants of normal retinal nerve fiber layer thickness measured by Stratus OCT. Ophthalmology (2007) 3.88
Choroidal thickness change after water drinking is greater in angle closure than in open angle eyes. Invest Ophthalmol Vis Sci (2012) 2.48
Persistence and adherence with topical glaucoma therapy. Am J Ophthalmol (2005) 2.31
Doctor-patient communication, health-related beliefs, and adherence in glaucoma results from the Glaucoma Adherence and Persistency Study. Ophthalmology (2008) 2.29
Translimbal laser photocoagulation to the trabecular meshwork as a model of glaucoma in rats. Invest Ophthalmol Vis Sci (2002) 2.24
Evaluation of practice patterns for the care of open-angle glaucoma compared with claims data: the Glaucoma Adherence and Persistency Study. Ophthalmology (2007) 2.20
Central corneal thickness and corneal hysteresis associated with glaucoma damage. Am J Ophthalmol (2006) 2.14
Adherence with topical glaucoma medication monitored electronically the Travatan Dosing Aid study. Ophthalmology (2008) 2.10
Development and validation of an improved neurological hemifield test to identify chiasmal and postchiasmal lesions by automated perimetry. Invest Ophthalmol Vis Sci (2014) 2.05
Risk factors and open-angle glaucoma: classification and application. J Glaucoma (2007) 1.99
The impact of visual impairment and eye disease on vision-related quality of life in a Mexican-American population: proyecto VER. Invest Ophthalmol Vis Sci (2002) 1.92
Biomechanics of the human posterior sclera: age- and glaucoma-related changes measured using inflation testing. Invest Ophthalmol Vis Sci (2012) 1.89
Gene therapy with brain-derived neurotrophic factor as a protection: retinal ganglion cells in a rat glaucoma model. Invest Ophthalmol Vis Sci (2003) 1.83
Visual field defects and retinal ganglion cell losses in patients with glaucoma. Arch Ophthalmol (2006) 1.83
Caspase activation and amyloid precursor protein cleavage in rat ocular hypertension. Invest Ophthalmol Vis Sci (2002) 1.82
Changes in gene expression in experimental glaucoma and optic nerve transection: the equilibrium between protective and detrimental mechanisms. Invest Ophthalmol Vis Sci (2007) 1.74
Choroidal thickness measured by spectral domain optical coherence tomography: factors affecting thickness in glaucoma patients. Ophthalmology (2011) 1.74
Risk factors for poor adherence to eyedrops in electronically monitored patients with glaucoma. Ophthalmology (2009) 1.74
Optic disc morphology in open-angle glaucoma compared with anterior ischemic optic neuropathies. Invest Ophthalmol Vis Sci (2009) 1.71
Adherence and persistence with glaucoma therapy. Surv Ophthalmol (2008) 1.57
Quantitative mapping of collagen fiber orientation in non-glaucoma and glaucoma posterior human sclerae. Invest Ophthalmol Vis Sci (2012) 1.56
Influence of corneal structure, corneal responsiveness, and other ocular parameters on tonometric measurement of intraocular pressure. J Glaucoma (2007) 1.52
Aqueous flow through the iris-lens channel: estimates of differential pressure between the anterior and posterior chambers. J Glaucoma (2004) 1.52
Outcomes and bleb-related complications of trabeculectomy. Ophthalmology (2012) 1.52
Differential susceptibility to experimental glaucoma among 3 mouse strains using bead and viscoelastic injection. Exp Eye Res (2010) 1.51
Estimating the rate of progressive visual field damage in those with open-angle glaucoma, from cross-sectional data. Invest Ophthalmol Vis Sci (2008) 1.47
A model to study differences between primary and secondary degeneration of retinal ganglion cells in rats by partial optic nerve transection. Invest Ophthalmol Vis Sci (2003) 1.46
Interventions improve poor adherence with once daily glaucoma medications in electronically monitored patients. Ophthalmology (2009) 1.46
The effect of experimental glaucoma and optic nerve transection on amacrine cells in the rat retina. Invest Ophthalmol Vis Sci (2005) 1.40
Functional genomic screening identifies dual leucine zipper kinase as a key mediator of retinal ganglion cell death. Proc Natl Acad Sci U S A (2013) 1.36
Comparison of limbus-based and fornix-based trabeculectomy: success, bleb-related complications, and bleb morphology. Ophthalmology (2012) 1.36
Gene delivery to the eye using adeno-associated viral vectors. Methods (2002) 1.35
Scleral anisotropy and its effects on the mechanical response of the optic nerve head. Biomech Model Mechanobiol (2012) 1.32
Effect of CNTF on retinal ganglion cell survival in experimental glaucoma. Invest Ophthalmol Vis Sci (2008) 1.31
Glaucoma management among individuals enrolled in a single comprehensive insurance plan. Ophthalmology (2005) 1.26
The impact of ocular adverse effects in patients treated with topical prostaglandin analogs: changes in prescription patterns and patient persistence. J Ocul Pharmacol Ther (2009) 1.26
Manometric calibration and comparison of TonoLab and TonoPen tonometers in rats with experimental glaucoma and in normal mice. J Glaucoma (2006) 1.25
Delay of insulin addition to oral combination therapy despite inadequate glycemic control: delay of insulin therapy. J Gen Intern Med (2007) 1.25
Retinal ganglion cell loss in a rat ocular hypertension model is sectorial and involves early optic nerve axon loss. Invest Ophthalmol Vis Sci (2011) 1.24
Clinician change detection viewing longitudinal stereophotographs compared to confocal scanning laser tomography in the LSU Experimental Glaucoma (LEG) Study. Ophthalmology (2002) 1.23
Factors influencing career choices among graduating ophthalmology residents. Ophthalmology (2005) 1.17
The effects of anesthesia, mouse strain and age on intraocular pressure and an improved murine model of experimental glaucoma. Exp Eye Res (2012) 1.17
In vivo time-lapse fluorescence imaging of individual retinal ganglion cells in mice. J Neurosci Methods (2007) 1.16
The association between glaucomatous visual fields and optic nerve head features in the Ocular Hypertension Treatment Study. Ophthalmology (2006) 1.16
Glaucomatous optic nerve injury involves early astrocyte reactivity and late oligodendrocyte loss. Glia (2010) 1.14
Calibration of the TonoLab tonometer in mice with spontaneous or experimental glaucoma. Invest Ophthalmol Vis Sci (2011) 1.13
Evaluation of a combined index of optic nerve structure and function for glaucoma diagnosis. BMC Ophthalmol (2011) 1.12
Impact of donepezil treatment for Alzheimer's disease on caregiver time. Curr Med Res Opin (2004) 1.12
The in vitro inflation response of mouse sclera. Exp Eye Res (2010) 1.11
Optic nerve dynein motor protein distribution changes with intraocular pressure elevation in a rat model of glaucoma. Exp Eye Res (2006) 1.09
Mice with an induced mutation in collagen 8A2 develop larger eyes and are resistant to retinal ganglion cell damage in an experimental glaucoma model. Mol Vis (2012) 1.09
Increased expression of iron-regulating genes in monkey and human glaucoma. Invest Ophthalmol Vis Sci (2004) 1.07
The TRAVATAN Dosing Aid accurately records when drops are taken. Am J Ophthalmol (2006) 1.06
Retinal ganglion cell morphology after optic nerve crush and experimental glaucoma. Invest Ophthalmol Vis Sci (2012) 1.06
Studies of scleral biomechanical behavior related to susceptibility for retinal ganglion cell loss in experimental mouse glaucoma. Invest Ophthalmol Vis Sci (2013) 1.04
Retinal glutamate transporter changes in experimental glaucoma and after optic nerve transection in the rat. Invest Ophthalmol Vis Sci (2002) 1.04
Scleral structural alterations associated with chronic experimental intraocular pressure elevation in mice. Mol Vis (2013) 1.03
Effect of patient-centered communication training on discussion and detection of nonadherence in glaucoma. Ophthalmology (2010) 1.03
Patterns of healthcare utilization and costs for vascular dementia in a community-dwelling population. J Alzheimers Dis (2005) 1.02
The transcription factor c-jun is activated in retinal ganglion cells in experimental rat glaucoma. Exp Eye Res (2005) 0.99
Gene expression profiling of purified rat retinal ganglion cells. Invest Ophthalmol Vis Sci (2004) 0.99
Outcomes of surgical bleb revision for complications of trabeculectomy. Ophthalmology (2009) 0.99
Comparison of dynamic changes in anterior ocular structures examined with anterior segment optical coherence tomography in a cohort of various origins. Invest Ophthalmol Vis Sci (2014) 0.98
Inactivation of mammalian target of rapamycin increases STAT1 nuclear content and transcriptional activity in alpha4- and protein phosphatase 2A-dependent fashion. J Biol Chem (2009) 0.96
A self-assessment instrument designed for measuring independent mobility in RP patients: generalizability to glaucoma patients. Invest Ophthalmol Vis Sci (2002) 0.95
Translating ocular biomechanics into clinical practice: current state and future prospects. Curr Eye Res (2014) 0.95
Doctor-patient communication in glaucoma care: analysis of videotaped encounters in community-based office practice. Ophthalmology (2009) 0.94
Variations in treatment among adult-onset open-angle glaucoma patients. Ophthalmology (2005) 0.94
Characteristics of progenitor cells derived from adult ciliary body in mouse, rat, and human eyes. Invest Ophthalmol Vis Sci (2007) 0.94
Household members of persons with Alzheimer's disease: health conditions, healthcare resource use, and healthcare costs. J Am Geriatr Soc (2014) 0.93
Evaluation of an algorithm for detecting visual field defects due to chiasmal and postchiasmal lesions: the neurological hemifield test. Invest Ophthalmol Vis Sci (2011) 0.92
The choroid is thicker in angle closure than in open angle and control eyes. Invest Ophthalmol Vis Sci (2012) 0.91
A 12-week, randomized, double-masked study of fixed combination latanoprost/timolol versus latanoprost or timolol monotherapy. Eur J Ophthalmol (2011) 0.91
Comparison of optic nerve head topography and visual field in eyes with open-angle and angle-closure glaucoma. Ophthalmology (2008) 0.91
Long-term outcomes in fellow eyes after acute primary angle closure in the contralateral eye. Ophthalmology (2006) 0.91
Can diabetes be good for glaucoma? Why can't we believe our own eyes (or data)? Arch Ophthalmol (2009) 0.90
In-office discussions of migraine: results from the American Migraine Communication Study. J Gen Intern Med (2008) 0.90
Factors affecting the decision to pursue glaucoma fellowship training. J Glaucoma (2007) 0.90
Increased choroidal thickness in patients with Sturge-Weber syndrome. JAMA Ophthalmol (2013) 0.90
Regional variations and trends in the prevalence of diagnosed glaucoma in the Medicare population. Ophthalmology (2012) 0.90
Fixed combination of latanoprost and timolol vs individual components for primary open-angle glaucoma or ocular hypertension: a randomized, double-masked study. Arch Ophthalmol (2010) 0.90
Pharmacological approaches to managing migraine and associated comorbidities--clinical considerations for monotherapy versus polytherapy. Headache (2007) 0.90
Cost-effectiveness model for neovascular age-related macular degeneration: comparing early and late treatment with pegaptanib sodium based on visual acuity. Value Health (2007) 0.90
Measurement of amino acid levels in the vitreous humor of rats after chronic intraocular pressure elevation or optic nerve transection. J Glaucoma (2002) 0.89
Heritable features of the optic disc: a novel twin method for determining genetic significance. Invest Ophthalmol Vis Sci (2007) 0.88
Gaze behavior of the visually impaired during street crossing. Optom Vis Sci (2006) 0.88
Ovarian sex cord-stromal tumors in patients with probable or confirmed germline DICER1 mutations. Int J Gynecol Pathol (2015) 0.88
Collagen structure and mechanical properties of the human sclera: analysis for the effects of age. J Biomech Eng (2015) 0.87
Patterns of cholinesterase-inhibitor use in the nursing home setting: a retrospective analysis. Am J Geriatr Pharmacother (2006) 0.87
What's the choroid got to do with angle closure? Arch Ophthalmol (2009) 0.86